Analyst Ranking
Bottom 5%
#5304 out of 5549 analysts
Average Return
-3.23%
Win Rate
40%61 out of 153
Risk vs Reward
Poor
Good

Brandon Folkes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Achieve Life Sciences IncACHV
+177.51%$2.89$8.02
2025-08-21 -
2026-08-20
Buy
Connect Biopharma Holdings LtdCNTB
+147.06%$0.85$2.10
2025-06-12 -
2026-06-11
Buy
Achieve Life Sciences IncACHV
+145.74%$2.82$6.93
2026-03-25 -
2026-10-27
Buy
Trevi Therapeutics IncTRVI
+130.83%$6.26$14.45
2025-05-28 -
2026-05-27
Buy
Elutia IncELUT
+130.77%$1.43$3.30
2023-08-15 -
2024-08-14
Strong Buy

Brandon Folkes Analyst Color

Get additional color on Brandon Folkes's coverage of popular stocks

Brandon Folkes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Journey Medical CorpDERM
4Buy$13.00+162.10%Reiterates
2 days ago
Connect Biopharma Holdings LtdCNTB
6Buy$7.00+730.37%Reiterates
20 days ago
Sagimet Biosciences IncSGMT
5Buy$29.00+178.31%Reiterates
23 days ago
Eupraxia Pharmaceuticals IncEPRX
8Buy$11.00+55.37%Reiterates
a month ago
Cardiol Therapeutics IncCRDL
5Buy$9.00+689.47%Reiterates
a month ago
Enanta Pharmaceuticals IncENTA
5Buy$20.00+64.20%Reiterates
a month ago
Milestone Pharmaceuticals IncMIST
5Buy$8.00+1,057.74%Reiterates
2 months ago
Rani Therapeutics Holdings IncRANI
6Buy$11.00+1,706.24%Reiterates
2 months ago
Zevra Therapeutics IncZVRA
3Buy$26.00+158.58%Reiterates
2 months ago
Rein Therapeutics IncRNTX
3Buy$8.00+1,036.36%Reiterates
2 months ago
Traws Pharma IncTRAW
4Hold$1.00+173.22%Reiterates
2 months ago
Heron Therapeutics IncHRTX
5HoldN/AN/ADowngrades
3 months ago
Polypid LtdPYPD
6Buy$13.00+125.30%Reiterates
3 months ago
Trevi Therapeutics IncTRVI
6Buy$24.00+79.78%Maintains
3 months ago
Omeros CorpOMER
7Buy$33.00+88.68%Maintains
4 months ago
Achieve Life Sciences IncACHV
5Buy$12.00+73.16%Reiterates
4 months ago
Talphera IncTLPH
1Buy$3.00+175.23%Assumes
5 months ago
Sintx Technologies IncSINT
2Buy$10.00+484.80%Reiterates
5 months ago
Mannkind CorpMNKD
10Buy$10.00+203.95%Maintains
6 months ago
Collegium Pharmaceutical IncCOLL
7Buy$60.00+160.87%Reiterates
7 months ago
Pelthos Therapeutics IncPTHS
2Buy$60.00+313.79%Reiterates
7 months ago
Xeris Biopharma Holdings IncXERS
5Buy$10.00-4.31%Reiterates
8 months ago
Cormedix IncCRMD
5Buy$13.00+62.50%Maintains
9 months ago
Indivior Pharmaceuticals IncINDV
3Buy$48.00+38.25%Maintains
10 months ago
Genfit SaGNFTY
2Buy$7.00N/AMaintains
a year ago
Ani Pharmaceuticals IncANIP
5Buy$121.00N/AMaintains
a year ago
Valneva SeVALN
2Buy$18.00N/AReiterates
a year ago
Rockwell Medical IncRMTI
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Adial Pharmaceuticals IncADIL
1Strong Buy$200.00N/AInitiates Coverage On
2 years ago
Emergent Biosolutions IncEBS
4Strong Buy$16.00N/AReiterates
2 years ago
Scilex Holding CoSCLX
1Strong Buy$455.00N/AInitiates Coverage On
2 years ago
Sanara Medtech IncSMTI
4Strong Buy$59.00N/AReiterates
3 years ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$180.00N/AReiterates
3 years ago
Elutia IncELUT
3Strong Buy$8.00N/AReiterates
3 years ago
Amryt Pharma PLCAMYT
2Hold$14.75N/ADowngrades
4 years ago
Veru IncVERU
3Strong Buy$220.00N/AMaintains
4 years ago
Sorrento Therapeutics IncSRNEQ
1Strong Buy$5.00N/AInitiates Coverage On
4 years ago
Obseva SaOBSVF
1Strong Buy$6.00N/AInitiates Coverage On
4 years ago
Alkermes PLCALKS
1Strong Buy$32.00N/AUpgrades
5 years ago
IMV IncIMVIQ
1Strong Buy$40.00N/AInitiates Coverage On
5 years ago
Redhill Biopharma LtdRDHL
1Strong Buy$22,000.00N/AInitiates Coverage On
5 years ago
Trevena IncTRVN
1Strong Buy$3,125.00N/AInitiates Coverage On
6 years ago
Optinose IncOPTN
3Strong Buy$315.00N/AReiterates
7 years ago
Eagle Pharmaceuticals IncEGRX
2Hold$46.00N/AMaintains
7 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$30.00N/AReiterates
7 years ago
Opiant Pharmaceuticals IncOPNT
1Strong Buy$42.00N/AMaintains
8 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Strong Buy$50.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.